Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-26 @ 1:00 AM
Study NCT ID:
NCT05718934
Status:
COMPLETED
Last Update Posted:
2024-02-20
First Post:
2022-11-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium
Sponsor:
Ciusss de L'Est de l'Île de Montréal
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-01
First Submit QC Date:
None
Study First Post Date:
2023-02-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-19
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL